Raymond Debbane, Director: Lexicon Pharmaceuticals LXRX Buy · Filed 02/18

Trade details

Type: Insider buy
Amount: $176,468.16
Shares · price: 133,688 sh · $1.32 a share
Held after: 1,654,186 sh
Stock: Lexicon Pharmaceuticals LXRX
Person: Raymond DebbaneDirector
Trade date: 26/02/18
Filed: 26/02/18
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +8.8%

Lexicon Pharmaceuticals trades, last 26 weeks

What else happened in Lexicon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Raymond Debbane's recent trades

Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$2,980
2,000 sh
$2,980
Filed 02/27
Traded 02/25
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$147K
100,000 sh
$147K
Filed 02/25
Traded 02/23
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$148K
100,000 sh
$148K
Filed 02/23
Traded 02/20
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$72K
50,000 sh
$72K
Filed 02/23
Traded 02/19
Raymond DebbaneDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$100.7K
76,857 sh
$100.7K
Filed 02/18
Traded 02/17

Raymond Debbane, Director — bought $176.5K of Lexicon Pharmaceuticals LXRX · 133,688 sh @ $1.32 | Whalegun